JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB19031

Anti-PKC 抗体

Anti-PKC antibody

Be the first to review this product! Submit a review

|

(17 Publications)

Rabbit Polyclonal KPCA antibody. Suitable for WB and reacts with Rat samples. Cited in 17 publications. Immunogen corresponding to Synthetic Peptide within Mouse Prkcb.

別名を表示する

Pkca, Prkca, Protein kinase C alpha type, PKC-A, PKC-alpha

1 Images
Western blot - Anti-PKC antibody (AB19031)
  • WB

Unknown

Western blot - Anti-PKC antibody (AB19031)

All lanes:

Western blot - Anti-PKC antibody (ab19031) at 0.5 µg/mL

All lanes:

Cell lysate prepared from rat kidney cells

Predicted band size: 77 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Rat

アプリケーション

WB

applications

免疫原

Synthetic Peptide within Mouse Prkcb. The exact immunogen used to generate this antibody is proprietary information.

P68404

特異性

ab19031 recognizes the alpha, beta and gamma isoforms of PKC.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-4 µg/mL", "WB-species-notes": "<p></p>" } } }

製品の詳細

This product is manufactured by BioVision, an Abcam company and was previously called 3450 Anti-PKC Polyclonal Antibody. 3450-100 is the same size as the 100 µg size of ab19031.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Protein kinase C (PKC) comprises a family of serine/threonine kinases with several isoforms such as PKC alpha beta and gamma among others. PKC enzymes play key roles in intracellular signaling particularly in mediating responses to growth factors hormones and other signals. PKC exhibits a molecular weight generally ranging around 77 to 97 kDa depending on the isoform. These enzymes show expression in many tissues but have high concentrations in the brain heart and lung. PKC activation often involves translocation to cellular membranes which is important for their signaling roles.
Biological function summary

PKC influences various cellular processes such as cell proliferation differentiation apoptosis and immune responses. It acts within larger protein complexes serving as a modulator of cellular functions. The activation of PKC leads to its association with different scaffolding proteins impacting a wide array of cell activities. PKC notably affects the function of other kinases and transcription factors demonstrating its integral role in managing cellular behavior and homeostasis.

Pathways

PKC participates in the phosphoinositide signaling pathway and the mitogen-activated protein kinase (MAPK) pathway. In these contexts PKC activation impacts proteins like Ras and Raf kinases which play roles in cellular growth and differentiation. By modulating these pathways PKC becomes an important component in signal transduction cascades influencing cell fate decisions. Understanding the interaction between PKC and these pathways helps in elucidating its role in maintaining normal cellular activities and responses to external stimuli.

PKC is linked to cancer and cardiovascular diseases. In cancer dysregulation of PKC activity often contributes to tumor growth and progression by altering pathways that control cell division and survival. PKC abnormally interacts with proteins like Bcl-2 promoting cell survival. In cardiovascular diseases changes in PKC signaling can impact heart function contributing to conditions like heart failure through interactions with proteins such as troponin. Research on PKC and these diseases can provide insights into developing targeted therapies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascades involving MAPK1/3 (ERK1/2) and RAP1GAP. Depending on the cell type, is involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation. In cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Depending on the cell type, exhibits anti-apoptotic function and protects cells from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, or mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (By similarity). Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (By similarity). Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (By similarity). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (By similarity).
See full target information Prkca

追加のターゲット

,

文献 (17)

Recent publications for all applications. Explore the full list and refine your search

Discover oncology 16:533 PubMed40237863

2025

miR-126-5p suppresses HeLa and Ishikawa cell proliferation and migration via the RICTOR/AKT pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xuan Zhang,Yanjing Yang,Yaqin Li,Wei Zhang,Xianfang Song

Cell transplantation 29:963689720946020 PubMed32749163

2020

The Combination of and Ligustrazine Protects Against Thrombolysis-Induced Hemorrhagic Transformation Through PKCδ/Marcks Pathway in Cerebral Ischemia Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Ruihuan Pan,Xialin Tang,Huajun Wang,Yan Huang,Kai Huang,Shanshan Ling,Mingchao Zhou,Jun Cai,Hongxia Chen,Yan Huang

Frontiers in cellular neuroscience 14:202 PubMed32733207

2020

Neuroprotective Effects of Adenosine A1 Receptor Signaling on Cognitive Impairment Induced by Chronic Intermittent Hypoxia in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yichun Zhang,Hongchao Cao,Xuehao Qiu,Danfen Xu,Yifeng Chen,Gregory N Barnes,Yunjia Tu,Adwoa Takyiwaa Gyabaah,Abdulla Husain Abdulla Ahmed Gharbal,Chenlei Peng,Jun Cai,Xiaohong Cai

Journal of inflammation (London, England) 17:18 PubMed32377171

2020

Inhibition of carrageenan-induced dental inflammatory responses owing to decreased TRPV1 activity by Dexmedetomidine.

Applications

Unspecified application

Species

Unspecified reactive species

Gang Lv,Guanhua Zhu,Maohua Xu,Xingping Gao,Qingfeng Xiao

Journal of cellular and molecular medicine 24:2901-2916 PubMed32000296

2020

Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.

Applications

Unspecified application

Species

Unspecified reactive species

Wei-Qiang Jia,Jian-Wei Zhu,Cheng-Yong Yang,Jun Ma,Tian-You Pu,Guo-Qiang Han,Ming-Ming Zou,Ru-Xiang Xu

Scientific reports 9:17747 PubMed31780674

2019

Statin-specific inhibition of Rab-GTPase regulates cPKC-mediated IKs internalization.

Applications

Unspecified application

Species

Unspecified reactive species

Elsa Ronzier,Xiaorong Xu Parks,Haani Qudsi,Coeli M Lopes

Scientific reports 9:15339 PubMed31653890

2019

Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.

Applications

Unspecified application

Species

Unspecified reactive species

Wanzhen Jiao,Jia-Fu Ji,Wenwen Xu,Wenjuan Bu,Yuanjie Zheng,Aihua Ma,Bojun Zhao,Qingfeng Fan

Phytomedicine : international journal of phytother 63:152982 PubMed31299593

2019

Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.

Applications

Unspecified application

Species

Unspecified reactive species

Bangjie Li,Junqian Rui,Xuejian Ding,Yifan Chen,Xinghao Yang

Heliyon 5:e01781 PubMed31193485

2019

Polyphenols of marine red macroalga ameliorate diabetic peripheral neuropathy in experimental animals.

Applications

Unspecified application

Species

Unspecified reactive species

Suman Samaddar,Raju Koneri

Journal of molecular and cellular cardiology 129:314-325 PubMed30898664

2019

Fluvastatin inhibits Rab5-mediated IKs internalization caused by chronic Ca-dependent PKC activation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaorong Xu Parks,Elsa Ronzier,Jin O-Uchi,Coeli M Lopes
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com